BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27835899)

  • 1. Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expression.
    Franz M; Grün K; Betge S; Rohm I; Ndongson-Dongmo B; Bauer R; Schulze PC; Lichtenauer M; Petersen I; Neri D; Berndt A; Jung C
    Oncotarget; 2016 Dec; 7(49):81241-81254. PubMed ID: 27835899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection.
    Franz M; Grün K; Richter P; Brehm BR; Fritzenwanger M; Hekmat K; Neri D; Gummert J; Figulla HR; Kosmehl H; Berndt A; Renner A
    Histochem Cell Biol; 2010 Nov; 134(5):503-17. PubMed ID: 20931338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension.
    Jung C; Grün K; Betge S; Pernow J; Kelm M; Muessig J; Masyuk M; Kuethe F; Ndongson-Dongmo B; Bauer R; Lauten A; Schulze PC; Berndt A; Franz M
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
    de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
    Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.
    Franz M; Brehm BR; Richter P; Gruen K; Neri D; Kosmehl H; Hekmat K; Renner A; Gummert J; Figulla HR; Berndt A
    J Mol Histol; 2010 Feb; 41(1):39-50. PubMed ID: 20232238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, B⁺ tenascin-C and ED-A⁺ fibronectin in dilated cardiomyopathy: potential impact on disease progression and patients' prognosis.
    Franz M; Berndt A; Neri D; Galler K; Grün K; Porrmann C; Reinbothe F; Mall G; Schlattmann P; Renner A; Figulla HR; Jung C; Küthe F
    Int J Cardiol; 2013 Oct; 168(6):5344-51. PubMed ID: 23998545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin synthesis, deposition, and isoforms in monocrotaline-induced pulmonary hypertensive rat lungs.
    Lipke DL; Aziz SM; Fagerland JA; Majesky M; Arcot SS
    Am J Physiol; 1996 Aug; 271(2 Pt 1):L208-15. PubMed ID: 8770058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
    Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
    Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of sesamin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary hypertension].
    Li XW; Gao YX; Li S; Yang JR
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(7):1355-61. PubMed ID: 26281561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.
    Franz M; Matusiak-Brückner M; Richter P; Grün K; Ziffels B; Neri D; Maschek H; Schulz U; Pfeil A; Jung C; Figulla HR; Gummert J; Berndt A; Renner A
    J Mol Histol; 2014 Oct; 45(5):519-32. PubMed ID: 24792713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica.
    Zelko IN; Zhu J; Ritzenthaler JD; Roman J
    Respir Res; 2016 Nov; 17(1):160. PubMed ID: 27894297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of GATA6 gene in lung tissue of rat with pulmonary hypertension].
    Liu B; Liu HM; Yu L; Sun XJ; Wei L; Wang XM; Zhou TF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):864-7, 875. PubMed ID: 17236581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valsartan attenuates pulmonary hypertension via suppression of mitogen activated protein kinase signaling and matrix metalloproteinase expression in rodents.
    Lu Y; Guo H; Sun Y; Pan X; Dong J; Gao D; Chen W; Xu Y; Xu D
    Mol Med Rep; 2017 Aug; 16(2):1360-1368. PubMed ID: 28586065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of all-trans retinoic acids (ATRA) on the expression of α-smooth muscle actin (α-SMA) in the lung tissues of rats with pulmonary arterial hypertension (PAH).
    Xin Y; Lv JQ; Wang YZ; Zhang J; Zhang X
    Genet Mol Res; 2015 Nov; 14(4):14308-13. PubMed ID: 26600489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis.
    Baldinger A; Brehm BR; Richter P; Bossert T; Gruen K; Hekmat K; Kosmehl H; Neri D; Figulla HR; Berndt A; Franz M
    Histochem Cell Biol; 2011 May; 135(5):427-41. PubMed ID: 21479812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose-derived regenerative cell therapy inhibits the progression of monocrotaline-induced pulmonary hypertension in rats.
    Eguchi M; Ikeda S; Kusumoto S; Sato D; Koide Y; Kawano H; Maemura K
    Life Sci; 2014 Nov; 118(2):306-12. PubMed ID: 24853385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.